Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-03-22

Clinical Trial Update: Preliminary Human Trial of NPI-028 [Phase 2]

View source ↗

Summary

Phase 2 trial of NPI-028 for alcohol use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NPI-028

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Alcoholism | Phase 2 | Status: WITHDRAWN